Home Fast RBC loading by fluorescent antibodies and nuclei staining dye and their potential bioanalytical applications
Article
Licensed
Unlicensed Requires Authentication

Fast RBC loading by fluorescent antibodies and nuclei staining dye and their potential bioanalytical applications

  • Mohamed K. Al-Essa ORCID logo EMAIL logo , Susanne Melzer , Attila Tarnok , Kamal A. Hadidi and Mohammed El-Khateeb
Published/Copyright: August 9, 2017
Become an author with De Gruyter Brill

Abstract

This study was designed to load different antibodies (Abs) and a fluorescent dye onto the red blood cell (RBC) surface. We have used fluorescein isothiocyanate (FITC)-conjugate anti-human Ab, CD22-PE (B-cell marker-phycoerythrin Ab), and 4′,6-diamidino-2-phenylindole (DAPI) for insertion over the RBC surface. In a first step, conjugation experiments were performed: in dimethyl sulfoxide (DMSO), RBCs were conserved and modified by succinic anhydride to create an additional -COOH group, and then activated with 3-(3-dimethylaminopropyl)carbodiimide-N-hydroxysuccinimide (EDC-NHS) in 2-(N-morpholino) ethanesulfonic acid hydrate buffer for insertion of labeled Abs or DAPI. In a second step, fluorescence signals were evaluated by microscopy and the mean fluorescence intensities of cell lysates were measured by spectrofluorometry. The results showed clear evidence for adsorption of FITC- and PE-labeled Abs to activated conserved RBCs. DAPI was adsorbed well also to DMSO-conserved RBCs without the need for an activation step. The DMSO conservation step was enough to create reactive RBCs for insertion of specific Abs and fluorescent dyes. The additional modification by succinic anhydride and activation with EDC-NHS resulted in two- to seven-fold increase in fluorescence signals, indicating a much higher RBC loading capacity. These Ab- and fluorescent dye-functionalized RBCs have potentially high application in developing new biomedical diagnostic and in vitro assay techniques.

Acknowledgments

The authors would like to thank DAAD and The University of Jordan for their support (Bilateral Exchange of Academics program, 50015739). Also, special thanks are given to the Translational Center for Regenerative Medicine (TRM) at Leipzig University, Jordan University Hospital, and National Center for Diabetes, Endocrinology and Genetics for their generous support and use of their facilities. Further, the authors thank the German Federal Ministry of Education and Research’s Translational Center for Regenerative Medicine TRM Leipzig (BMBF, PtJ-Bio, 315883) and MaDaKos (BMBF, 16N10872, 990101-088) for grant support.

References

1. Muzykantov VR. Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert Opin Drug Deliv 2010;7:403–27.10.1517/17425241003610633Search in Google Scholar PubMed PubMed Central

2. Pierige F, Serafini S, Rossi L, Magnani M. Cell-based drug delivery. Adv Drug Deliv Rev 2008;60:286–95.10.1016/j.addr.2007.08.029Search in Google Scholar PubMed

3. Antonelli A, Sfara C, Manuali E, Bruce IJ, Magnani M. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents. Nanomedicine 2011;6:211–23.10.2217/nnm.10.163Search in Google Scholar PubMed

4. Kornfield TE, Newman EA. Measurement of retinal blood flow using fluorescently labeled red blood cells. eNeuro 2015;2: ENEURO.0005-15.2015. doi: 10.1523/ENEURO.0005-15.2015.10.1523/ENEURO.0005-15.2015Search in Google Scholar PubMed PubMed Central

5. Shi J, Kundrat L, Pishesha N, Bilate A, Theile C, Maruyama T, et al. Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes. Proc Natl Acad Sci USA 2014;111:10131–6.10.1073/pnas.1409861111Search in Google Scholar PubMed PubMed Central

6. Selvamani P, Latha S, Monisha A, Supassri T. A review on resealed erythrocyte as a novel drug delivery system. Asian J Pharm Clin Res 2015;8:101–7.Search in Google Scholar

7. Sternberg N, Georgieva R, Duft K, Bäumler H. Surface-modified loaded human red blood cells for targeting and delivery of drugs. J Microencapsul 2012;29:9–20.10.3109/02652048.2011.629741Search in Google Scholar PubMed

8. Callahan RJ, Froelich JW, McKusick KA, Leppo J, Strauss HW. A modified method for the in vivo labeling of red blood cellswith Tc-99m: concise communication. J Nucl Med 1982;23:315–8.Search in Google Scholar

9. Mock DM, Widness JA, Strauss RG, Franco RS. Posttransfusion red blood cell (RBC) survival determined using biotin-labeled RBCs has distinct advantages over labeling with 51Cr. Transfusion 2012;52:1596–8.10.1111/j.1537-2995.2012.03588.xSearch in Google Scholar PubMed PubMed Central

10. Saha GB. Characteristics of specific radiopharmaceuticals. In: Saha GB, editor. Fundamentals of nuclear pharmacy, 6th ed., Chapter 7. New York: Springer-Verlag, 2010, 115–52.10.1007/978-1-4419-5860-0_7Search in Google Scholar

11. Ferrauto G, Di Gregorio E, Dastrù W, Lanzardo S, Aime S. Gd-loaded-RBCs for the assessment of tumor vascular volume by contrast-enhanced-MRI. Biomaterials 2015;58:82–92.10.1016/j.biomaterials.2015.04.026Search in Google Scholar PubMed

12. Antonelli A, Magnani M. Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications. J Biomed Nanotechnol 2014;10:1732–50.10.1166/jbn.2014.1916Search in Google Scholar PubMed

13. Boni A, Ceratti D, Antonelli A, Sfara C, Magnani M, Manuali E, et al. USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study. Contrast Media Mol Imaging 2014;9:229–36.10.1002/cmmi.1562Search in Google Scholar PubMed

14. Mock DM, Lankford GL, Widness JA, Burmeister LF, Kahn D, Strauss RG. Measurement of circulating red cell volume using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion 1999;39:149–55.10.1046/j.1537-2995.1999.39299154728.xSearch in Google Scholar PubMed

15. Mock DM, Widness JA, Veng-Pedersen P, Strauss RG, Cancelas JA, Cohen RM, et al. Measurement of post transfusion red cell survival with the biotin label. Transfus Med Rev 2014;28: 114–25.10.1016/j.tmrv.2014.03.003Search in Google Scholar

16. Owens SD, Johns JL, Walker NJ, Librach FA, Carrade DD, Tablin F, et al. Use of an in vitro biotinylation technique for determination of posttransfusion survival of fresh and stored autologous red blood cells in thoroughbreds. Am J Vet Res 2010;71:960–6.10.2460/ajvr.71.8.960Search in Google Scholar

17. Hierholzer JC, Suggs MT, Hall EC. Standardized viral hemagglutination and hemagglutination-inhibition tests: II. Description and statistical evaluation. Appl Microbiol 1969;18:824–33.10.1128/am.18.5.824-833.1969Search in Google Scholar PubMed

18. Gupta RK, Sharma SB, Ahuja S, Saxena SN. Indirect (passive) haemagglutination test for assay of antigen and antibody (a review). Acta Microbiol Hung 1991;38:81–90.Search in Google Scholar PubMed

19. Bischoff FZ, Marquéz-Do DA, Martinez DI, Dang D, Horne C, Lewis D, et al. Intact fetal cell isolation from maternal blood: improved isolation using a simple whole blood progenitor cell enrichment approach (RosetteSep). Clin Genet 2003;63: 483–9.10.1034/j.1399-0004.2003.00087.xSearch in Google Scholar PubMed

20. Warren HS, Rana PM. An economical adaptation of the RosetteSep procedure for NK cell enrichment from whole blood, and its use with liquid nitrogen stored peripheral blood mononuclear cells. J Immunol Methods 2003;280:135–8.10.1016/S0022-1759(03)00106-6Search in Google Scholar PubMed

21. Bocsi J, Nieschke K, Mittag A, Reichert T, Laffers W, Marecka M, et al. Diagnosis of myocardial infarction based on lectin-induced erythrocyte agglutination – a feasibility study. In: Imaging, manipulation, and analysis of biomolecules, cells, and tissues XII. Proc. SPIE 2014;8947, Article No. 89470V.10.1117/12.2037702Search in Google Scholar

22. Whaun JM, Rittershaus C, Ip SH. Rapid identification and detection of parasitized human red cells by automated flow cytometry. Cytometry 1983;4:117–22.10.1002/cyto.990040204Search in Google Scholar PubMed

23. van Beers EJ, Samsel L, Mendelsohn L, Saiyed R, Fertrin KY, Brantner CA, et al. Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease. Am J Hematol 2014;89:598–603.10.1002/ajh.23699Search in Google Scholar PubMed PubMed Central

24. Piagnerelli M, Zouaoui Boudjeltia K, Brohee D, Vereerstraeten A, Piro P, Vincent JL, et al. Assessment of erythrocyte shape by flow cytometry techniques. J Clin Pathol 2007;60:549–54.10.1136/jcp.2006.037523Search in Google Scholar PubMed

25. Kennedy GA, Shaw R, Just S, Bryson G, Battistutta F, Rowell J, et al. Quantification of feto-maternal haemorrhage (FMH) by flow cytometry: anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D. Transfus Med 2003;13:25–33.10.1046/j.1365-3148.2003.00416.xSearch in Google Scholar PubMed

26. Nacharaju P, Boctor FN, Manjula BN, Acharya SA. Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: an approach to mask A, B, and D antigens to generate universal red blood cells. Transfusion 2005;45:374–83.10.1111/j.1537-2995.2005.04290.xSearch in Google Scholar

27. Corinti S, Chiarantini L, Dominici S, Laguardia ME, Magnani M, Girolomoni G. Erythrocytes deliver Tat to interferon-γ-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro. J Leukoc Biol 2002;71:652–8.10.1189/jlb.71.4.652Search in Google Scholar PubMed

28. Dominici S, Laguardia ME, Serafini G, Chiarantini L, Fortini C, Tripiciano A, et al. Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. Vaccine 2003;21:2073–81.10.1016/S0264-410X(02)00746-6Search in Google Scholar PubMed

29. Fang RH, Hu CM, Chen KN, Luk BT, Carpenter CW, Gao W, et al. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale 2013;5:8884–8.10.1039/c3nr03064dSearch in Google Scholar PubMed

30. Mukthavaram R, Shi G, Kesari S, Simberg D. Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes. J Control Release 2014;183:146–53.10.1016/j.jconrel.2014.03.038Search in Google Scholar PubMed

31. Taylor RP, Sutherland WM, Reist CJ, Webb DJ, Wright EL, Labuguen RH. Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment. Proc Natl Acad Sci USA 1991;88:3305–9.10.1073/pnas.88.8.3305Search in Google Scholar

32. Grabarek Z, Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990;185:131–5.10.1016/0003-2697(90)90267-DSearch in Google Scholar

33. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 2003;65:1035–41.10.1016/S0006-2952(03)00002-9Search in Google Scholar PubMed

34. Sputtek A, Kuhnl P, Rowe AW. Cryopreservation of erythrocytes, thrombocytes, and lymphocytes. Transfus Med Hemother 2007;34:262–7.10.1159/000104136Search in Google Scholar

35. Graham JE, Meola DM, Kini NR, Hoffman AM. Comparison of the effects of glycerol, dimethyl sulfoxide, and hydroxyethyl starch solutions for cryopreservation of avian red blood cells. Am J Vet Res 2015;76:487–93.10.2460/ajvr.76.6.487Search in Google Scholar PubMed

36. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54.10.1016/0003-2697(76)90527-3Search in Google Scholar PubMed

37. Soni B, Visavadiya NP, Dalwadi N, Madamwar D, Winder C, Khalil C. Purified c-phycoerythrin: safety studies in rats and protective role against permanganate-mediated fibroblast-DNA damage. J Appl Toxicol 2010;30:542–50.10.1002/jat.1524Search in Google Scholar PubMed

38. Sekar S, Chandramohan M. Phycobiliproteins as a commodity: trends in applied research, patents and commercialization. J Appl Phycol 2008;20:113–36.10.1007/s10811-007-9188-1Search in Google Scholar

39. Alford R, Simpson HM, Duberman J, Hill GC, Ogawa M, Regino C, et al. Toxicity of organic fluorophores used in molecular imaging: literature review. Mol Imaging 2009;8:341–54.10.2310/7290.2009.00031Search in Google Scholar PubMed

40. Xu K, Tzankova V, Li C, Sharma S. Intravenousfluorescein angiography-associated adverse reactions. Can J Ophthalmol 2016;51:321–5.10.1016/j.jcjo.2016.03.015Search in Google Scholar PubMed

41. Hara T, Inami M, Hara T. Efficacy and safety of fluorescein angiography with orally administered sodium fluorescein. Am J Ophthalmol 1998;126:560–4.10.1016/S0002-9394(98)00112-3Search in Google Scholar PubMed

42. Reeves KJ, Brookes ZL, Reed MW, Brown NJ. Evaluation of fluorescent plasma markers for in vivo microscopy of the microcirculation. J Vasc Res 2012;49:132–43.10.1159/000331281Search in Google Scholar PubMed

43. Martin JP, Logsdon N. Oxygen radicals mediate cell inactivation by acridine dyes, fluorescein, and lucifer yellow CH. Photochem Photobiol 1987;46:45–53.10.1111/j.1751-1097.1987.tb04734.xSearch in Google Scholar PubMed

44. Atale N, Gupta S, Yadav UC, Rani V. Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclearstainingtechniques. J Microsc 2014;255:7–19.10.1111/jmi.12133Search in Google Scholar PubMed

45. Wong LK, Reinertson EL. Clinical considerations of dimethyl sulfoxide. Iowa State Univ Vet 1984;46:Article 2.Search in Google Scholar

46. Bax BE, Bain MD, Talbot PJ, Parker-Williams EJ, Chalmers RA. Survival of human carrier erythrocytes in vivo. Clin Sci 1999;96:171–8.10.1042/cs0960171Search in Google Scholar PubMed

Received: 2017-3-28
Revised: 2017-5-22
Accepted: 2017-7-10
Published Online: 2017-8-9
Published in Print: 2018-2-23

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 3.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/znc-2017-0054/html
Scroll to top button